Skip to main navigation
Company Logo
  • About
    • About Overview
    • Leadership
    • Careers
  • Product
    • RECELL® System
  • Clinical Development
    • Pipeline/Clinical Trials
    • Patient Outcomes
    • Proof Assets
  • News & Media
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials
    • Annual Reports & Proxy
    • Stock Information
    • Corporate Governance
    • FAQ
    • Email Alerts
    • Contact
  • Contact
  • Search
  • Overview
  • Press Releases
  • Events & Presentations
  • Financials
  • Annual Reports & Proxy
  • Stock Information
  • Corporate Governance
  • FAQ
  • Email Alerts
  • Contact
/press-releases/news-releases
global

Investors: Press Releases

AVITA Medical to Host Investor Webinar Briefing
August 8, 2024
Learn More
AVITA Medical Reports Second Quarter Financial Results
August 8, 2024
Learn More
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
August 1, 2024
Learn More
  • News Releases
  • Announcements
August 8, 2024
AVITA Medical to Host Investor Webinar Briefing
August 8, 2024
AVITA Medical Reports Second Quarter Financial Results
August 1, 2024
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
July 31, 2024
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
July 11, 2024
AVITA Medical to Announce Second Quarter 2024 Financial Results
July 1, 2024
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
June 5, 2024
AVITA Medical Achieves Milestone with First Case Using RECELL GO
May 30, 2024
AVITA Medical Announces FDA Approval of RECELL GO
May 16, 2024
AVITA Medical to Host Investor Webinar Briefing
May 13, 2024
AVITA Medical Reports First Quarter Financial Results
April 15, 2024
AVITA Medical to Announce First Quarter 2024 Financial Results
April 10, 2024
AVITA Medical Updates Expected First Quarter 2024 Revenue
February 29, 2024
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
February 29, 2024
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
February 23, 2024
AVITA Medical to Host Investor Webinar Briefing
February 22, 2024
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
February 1, 2024
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
January 10, 2024
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
January 10, 2024
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
January 4, 2024
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
AVITA Medical, Inc. Logo with tag

Contact Investor Relations

Jessica Ekeberg
Director, Investor Relations
investor@avitamedical.com

Request Email Alerts
® 2024 AVITA Medical, Inc.
  • Terms of Use
  • Privacy Policy
  • CA Compliance
  • Social Media
  • CCPA
  • Compliance and Ethics
  • Important Safety Information

Social Media

  • Twitter (opens in new window)
  • Linkedin (opens in new window)